Key Takeaways
- The firms recently announced they will operate as LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands.
- Patient Square has been majority-owned Eargo since acquiring 76% of its stock in 2022.
- Research reports US OTC hearing aid market in 2023 was $123.3m and estimates 5.8% CAGR between 2024 and 2032.
The US OTC hearing aid market has grown enough since starting in 2022 to prompt not only the merger of two leading firms focused on the space, Eargo Inc. and...
The firms recently announced they will operate as LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?